15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.
about
Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma.Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.Novel agents in mantle cell lymphoma.Current and emerging treatment options for mantle cell lymphoma.Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.Post-autologous transplant maintenance therapies in lymphoma: current state and future directions.Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies.VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.Current trials for frontline therapy of mantle cell lymphoma.Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party.Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.
P2860
Q38630219-33D5A5FB-FE17-4F83-83DB-AC07609E010BQ39175963-B1647B0E-2252-42F9-90D6-C3DDD0B3BE62Q39230986-09DD4C87-A140-4450-A3EA-3865B74A0C7CQ39290199-735EA261-106C-4D30-B11C-4F7FC22239C0Q41254748-CAB38ABA-6C4A-41C0-BB75-2AB8085D4E6FQ47237352-2CCC3261-18B6-45E9-900C-FBE8476DFA16Q47886065-7AF72B92-0B9C-4FA6-AAD0-79C87471A747Q48199074-ADDF06EF-D4D1-47CF-BBB5-FA43D9334524Q48546805-D77C462A-EED5-4DB1-8CE7-9B58A278A7C5Q49279565-3ED290B1-9FB5-4FC4-BC96-392FE1DC06A7Q50042359-17C481D5-C3F5-4ED0-A7BB-24E4BF53DCB4Q50205176-F5FF55DA-EAEB-443C-9E07-F60DA383FE88Q55610546-7EB9D3EB-7E05-490D-ABF1-4A77160E7CBE
P2860
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
15-year follow-up of the Secon ...... ions without survival plateau.
@en
type
label
15-year follow-up of the Secon ...... ions without survival plateau.
@en
prefLabel
15-year follow-up of the Secon ...... ions without survival plateau.
@en
P2093
P2860
P50
P356
P1476
15-year follow-up of the Secon ...... ions without survival plateau.
@en
P2093
Anna Laurell
Arne Kolstad
Christer Sundström
Christian Garde
Christian H Geisler
Elisabeth Ralfkiaer
Erkki Elonen
Grete F Lauritzsen
Hans Bentzen
P2860
P304
P356
10.1111/BJH.14241
P407
P50
P577
2016-07-05T00:00:00Z